In turn, GRα is repressed by Akt1, which phosphorylates its S134 residue [170] GRβ is preferentially expressed with AR in breast tumors and was revealed to be present in 92.1% of specimens, typically in triple-negative tumors. This evidence concerns the gene AR and breast neoplasm.